Top news of the week: 22.12.2020.
Career And Jobs
Enemy or Valuable Ally? How Biotech Uses Viruses for Good
Taking advantage of the ability of viruses to manipulate life is opening new doors for the biotech industry. Once only seen as our enemies, viruses are fast becoming some of our most ...
Biopharma Money on the Move: December 9-15
A roundup of life sciences companies raking in the cash.
Ginkgo Bioworks Acquires Biotechnology Startup Novogy’s Microbial Engineering Platform
Biotech leader will absorb Novogy’s research codebase, technology, and technical expertise to support Ginkgo to scale platform capacity, bolster internal expertise BOSTON, Dec. 16, 2020 ...
Amgen Awards Two Local Biotech Start-Ups With Golden Ticket To LabCentral
CAMBRIDGE, Mass., Dec. 17, 2020 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and LabCentral today announced that Octagon Therapeutics and Seranova Bio have each won an Amgen Golden Ticket to ...
Ginkgo Bioworks Acquires Biotechnology Startup Novogy's Microbial Engineering Platform
BOSTON, Dec. 16, 2020 /PRNewswire/ -- Ginkgo Bioworks ("Ginkgo"), the organism company, today announced that it has recently completed an acquisition of the main assets of Novogy, Inc. ...
Top 15 Biotech Companies Shaking up the Scene in Cambridge
Cambridge has a large biotech scene that is starting to rival that of its US namesake. Here are the top 15 biotech companies in Cambridge you should know about. Cambridge is a small but ...
Four Potential Biotech Market Movers to Watch Going into 2021
As we eagerly look ahead to 2021, BioSpace spoke to four biotechs hoping to seize this opportunity in the first wave of COVID-19 vaccines and therapies – or make an impact in the second.
Neuro Biotech Scooped Up by Novartis in $770 Million Deal
Novartis is acquiring Cambridge, Massachusetts-based Cadent Therapeutics for $210 million up front and a possible $560 million in milestone payments.